Boosting leukemia-specific T cell responses in patients following stem cell transplantation

Whole tumor cell-based vaccines administered within the first 2 to 3 months after allogeneic stem cell transplantation stand out as a promising approach to enhance graft-vs.-leukemia responses. Herein, the implications of this finding for the development of strategies to improve the outcome of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Burkhardt, Ute E, Wu, Catherine J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897523/
https://www.ncbi.nlm.nih.gov/pubmed/24482749
http://dx.doi.org/10.4161/onci.26587
_version_ 1782300248145657856
author Burkhardt, Ute E
Wu, Catherine J
author_facet Burkhardt, Ute E
Wu, Catherine J
author_sort Burkhardt, Ute E
collection PubMed
description Whole tumor cell-based vaccines administered within the first 2 to 3 months after allogeneic stem cell transplantation stand out as a promising approach to enhance graft-vs.-leukemia responses. Herein, the implications of this finding for the development of strategies to improve the outcome of patients subjected to allogeneic stem cell transplantation are discussed.
format Online
Article
Text
id pubmed-3897523
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-38975232014-01-30 Boosting leukemia-specific T cell responses in patients following stem cell transplantation Burkhardt, Ute E Wu, Catherine J Oncoimmunology Author's View Whole tumor cell-based vaccines administered within the first 2 to 3 months after allogeneic stem cell transplantation stand out as a promising approach to enhance graft-vs.-leukemia responses. Herein, the implications of this finding for the development of strategies to improve the outcome of patients subjected to allogeneic stem cell transplantation are discussed. Landes Bioscience 2013-11-01 2013-10-10 /pmc/articles/PMC3897523/ /pubmed/24482749 http://dx.doi.org/10.4161/onci.26587 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Burkhardt, Ute E
Wu, Catherine J
Boosting leukemia-specific T cell responses in patients following stem cell transplantation
title Boosting leukemia-specific T cell responses in patients following stem cell transplantation
title_full Boosting leukemia-specific T cell responses in patients following stem cell transplantation
title_fullStr Boosting leukemia-specific T cell responses in patients following stem cell transplantation
title_full_unstemmed Boosting leukemia-specific T cell responses in patients following stem cell transplantation
title_short Boosting leukemia-specific T cell responses in patients following stem cell transplantation
title_sort boosting leukemia-specific t cell responses in patients following stem cell transplantation
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897523/
https://www.ncbi.nlm.nih.gov/pubmed/24482749
http://dx.doi.org/10.4161/onci.26587
work_keys_str_mv AT burkhardtutee boostingleukemiaspecifictcellresponsesinpatientsfollowingstemcelltransplantation
AT wucatherinej boostingleukemiaspecifictcellresponsesinpatientsfollowingstemcelltransplantation

Ejemplares similares